文献速递主动脉疾病

八十岁及以上高龄患者胸主动脉腔内修复术的经验

Thoracic Endovascular Aortic Repair in Octogenarians and Nonagenarians.
PubMed 文献 · Ann Vasc Surg · 2020-05-18

退行性动脉瘤占60%,64%有症状,平均最大主动脉直径62.7±15.6毫米。院内死亡率12%,30天死亡率16%,术后并发症与30天死亡率风险显著增加相关(P<0.01)。结论认为在适当选择的患者中,高龄本身不应成为TEVAR的禁忌。

要点

  • 80岁及以上患者TEVAR院内死亡率12%,30天死亡率16%。
  • 术后并发症与30天死亡率风险显著增加相关(P<0.01)。
  • 在适当选择的患者中,高龄本身不应视为TEVAR的禁忌。

核心结论

  • 尽管高龄患者手术风险固有升高,本研究显示TEVAR在八十岁和九十岁患者中成功率合理。
  • 在适当选择的患者中,高龄本身不应成为TEVAR的禁忌因素。

研究设计与样本

  • 单中心回顾性分析,使用前瞻性维护数据库,纳入2014年1月至2019年1月所有80岁及以上接受TEVAR的患者。

主要发现

  • 术前最常见合并症为高血压(24例,96%)和吸烟(18例,72%),平均改良衰弱指数0.32±0.17。
  • 退行性动脉瘤占主动脉病理的60%,大多数患者有症状(64%),平均最大主动脉直径62.7±15.6毫米。
  • 内漏见于3例(12%)患者,ICU住院时间2.0(1.5,3.0)天,总住院时间5.0(3.0,7.0)天。
  • 院内死亡率12%(3例),总30天死亡率16%(4例),中位随访469.0(76.0,586.0)天。
  • 单因素分析显示术后并发症与30天死亡率风险显著增加相关(P<0.01)。

临床怎么用

  • 对于80岁及以上胸主动脉疾病患者,TEVAR可考虑用于适当选择的人群,高龄本身不应作为禁忌。
  • 术后并发症与30天死亡率风险增加相关,应重视围手术期并发症的预防和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The oldest segments of the population are expanding rapidly, and the number of thoracic endovascular aortic repairs (TEVARs) performed in the elderly parallels this trend. We describe our institutional TEVAR experience in octogenarians and nonagenarians. METHODS: All patients 80 years and older undergoing TEVAR at a single institution were reviewed using a prospectively maintained database. Baselines demographics, operative details, and outcomes were retrospectively analyzed. RESULTS: Twenty-five octogenarians and nonagenarians (age, 84.8 ± 3.7 years; 64% male) underwent TEVAR between January 2014 and January 2019. The most common preoperative comorbidities were hypertension (n = 24; 96%) and tobacco use (n = 18; 72%), and the mean modified frailty index was 0.32 ± 0.17. Degenerative aneurysms constituted the majority of aortic pathologies (60%), and most patients were symptomatic (64%), with a mean maximal aortic diameter of 62.7 ± 15.6 mm. Endoleaks were noted in 3 (12%) patients. Intensive care unit length of stay was 2.0 (1.5, 3.0) days, and the total length of stay was 5.0 (3.0, 7.0) days. In-hospital mortality was 12% (n = 3), while the overall 30-day mortality was 16% (n = 4). The median follow-up was 469.0 (76.0, 586.0) days. On univariate analysis, the presence of a postoperative complication was associated with a significantly increased risk of 30-day mortality (P < 0.01). CONCLUSIONS: Despite the inherently elevated operative risk among the elderly, this study demonstrates reasonable success rates for TEVAR in octogenarian and nonagenarian patients. In properly selected patients, advanced age alone should not be a prohibitive factor for TEVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Akhmerov A, Shah AS, Gupta N, et al. Thoracic Endovascular Aortic Repair in Octogenarians and Nonagenarians. Ann Vasc Surg. 2020. PMID: 32439524. doi:10.1016/j.avsg.2020.04.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。